Funding for Biomarkers Across Neurodegenerative Diseases

For the second year, PPMI is participating in the Biomarkers Across Neurodegenerative Diseases (BAND) program.  The Alzheimer’s Association, Alzheimer’s Research UK, The Michael J. Fox Foundation and the Weston Brain Institute announce a collaborative Request for Applications to stimulate analyses across Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases toward, for example, biomarker discovery, assay standardization, genetic profiling, and imaging development. Recent evidence suggests substantial overlap between these diseases pathologically, but also, potentially, biologically. The program is designed to enable pilot research or proof-of-principle studies utilizing data from large biomarker studies. Proposed projects must use resources from at least one either AD or PD cohort such as the Alzheimer’s Disease Neuroimaging Initiative or PPMI. Data may come from investigator-chosen cohorts, including of other neurodegenerative disease patients. The program offers resources from a frontotemporal lobar dementia (FTLD) cohort study.

Visit Biomarkers Across Neurodegenerative Diseases (BAND) for more information and to apply.

Important Dates

Conference Call: March 12, 2015 at 12pm US ET

The Michael J. Fox Foundation will hold a 45-minute call to explain the goals of this funding initiative. To receive call-in details, RSVP to conferencecalls@michaeljfox.org.

Pre-Proposals Due: April 9, 2015 by 6pm US ET